Infliximab and adalimumab, unlike ustekinumab, increase serum KL-6 levels in Japanese patients with psoriasis.

Published in:

Journal of Dermatology, 2015, v. 42, n. 8, p. 828, doi. 10.1111/1346-8138.12918

By:

• Yanaba, Koichi;
• Umezawa, Yoshinori;
• Sakakihara, Reiko;
• Chiba, Miki;
• Ito, Toshihiro;
• Kikuchi, Sota;
• Fukuchi, Osamu;
• Asahina, Akihiko;
• Saeki, Hidehisa;
• Nakagawa, Hidemi

Publication type:

Article